title: RVUs and DRGs: do they fairly reimburse physicians and hospitals and incentivize improved care?
authors: College of Physicians and Surgeons, Columbia University Medical Center, 3959 Broadway, CHN 1200A, New York, NY 10032, USA. sdr26@columbia.edu
authors: David
authors: D
authors: Rubenstein
authors: Glenna
authors: G
authors: Friedman
authors: David
authors: D
authors: Bateman
mesh_terms: D000293:Adolescent; D001205:Ascorbic Acid / Q000031:analogs & derivatives; D001291:Attitude of Health Personnel; D002648:Child; D002675:Child, Preschool; D003953:Diagnosis-Related Groups / Q000191:economics* / Q000331:legislation & jurisprudence*; D005251:Fees, Medical / Q000331:legislation & jurisprudence*; D005260:Female; D017721:Hospital Costs / Q000331:legislation & jurisprudence*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007348:Insurance, Health / Q000191:economics* / Q000331:legislation & jurisprudence*; D008484:Medicaid / Q000191:economics* / Q000331:legislation & jurisprudence*; D006278:Medicare / Q000191:economics* / Q000331:legislation & jurisprudence*; D009285:Naphthoquinones; D010372:Pediatrics / Q000191:economics* / Q000331:legislation & jurisprudence*; D011247:Pregnancy; D058996:Quality Improvement / Q000191:economics*; D012052:Reimbursement, Incentive / Q000191:economics* / Q000331:legislation & jurisprudence*; D015895:Relative Value Scales; D014481:United States
chemical_list: C562098:A80915B; D009285:Naphthoquinones; C087337:6-S-hexadecyl-2-methoxythioascorbic acid; D001205:Ascorbic Acid